Review: Oral and intravaginal agents are equally effective for treatment of uncomplicated vulvovaginal candidiasis

Harper, Diane
July 2002
ACP Journal Club;Jul/Aug2002, Vol. 137 Issue 1, p15
Academic Journal
Provides information on a study that investigated whether oral and intravaginal antifungal agents are equally effective, safe and cost-effective for uncomplicated vulvovaginal candidiasis. Data sources; Study selection; Main results; Conclusions.


Related Articles

  • Oral Fluconazole for Vaginal Candidiasis. Desai, Parimal C.; Johnson, Brett A. // American Family Physician;9/15/1996, Vol. 54 Issue 4, p1337 

    Discusses the use of oral fluconazole for the treatment of vaginal candidiasis. Fungicidal action; Pharmacokinetics; Dosage; Cost; Indications and contraindications; Clinical trials that compare its efficacy with intravaginal agents; Adverse effects and drug interactions.

  • FDA approves expanded indication for fluconazole. Hurley, Mary Lou // RN;Feb95, Vol. 58 Issue 2, p78 

    Reports on the availability of the antifungal agent fluconazole (Diflucan) as a single-dose 150 mg tablet to treat vaginal candidiasis. Side effects; Absence of compliance problems; `FDC Reports' as source of information.

  • The Effect of Ambulation on Vaginal Distribution of Miconazole Nitrate (1200 mg). Menon, Seema; Izquierdo, Adrianna; Rosen, Mark; Hummel, Amy; Barnhart, Kurt // Journal of Women's Health (15409996);Jun2007, Vol. 16 Issue 5, p703 

    Objective: To evaluate the effect activity has on the vaginal distribution of a 1200 mg miconazole nitrate gelatin encapsulated insert, an antifungal agent commonly used to treat vaginal vulvocandidiasis. Method: Nine subjects underwent two sessions of serial magnetic resonance imaging after...

  • Lomexin.  // Royal Society of Medicine: Medicines;2002, p339 

    The article presents information on the drug lomexin from Akita. Lomexin is a proprietary, prescription-only preparation of the antifungal drug fenticonazole nitrate. It can be used to treat vaginal candidiasis or thrush. It is available as vaginal pessaries.

  • Fluconazole: Most cost-effective vaginal candidiasis treatment, modeling study finds.  // Formulary;Mar1999, Vol. 34 Issue 3, p278 

    Compares different antifungal medications used in treating vaginal candidiasis. Goal of reducing nursing administration time, biological waste, soiling of clothing and bedding; Drug acquisition costs for fluconazole, nystatin, clotrimazole and miconazole.

  • Fluconazole.  // Reactions Weekly;9/18/2010, Issue 1319, p24 

    The article describes the case of a 64-year-old woman who presented with a 3-day history of several well-demarcated, erythematous ovoid patches on her arms, palms and lower leg after receiving treatment with oral fluconazole for vaginal candidiasis.

  • Vaginitis Due to Candida krusei: Epidemiology, Clinical Aspects, and Therapy. Singh, Shivani; Sobel, Jack D.; Bhargava, Pallavi; Boikov, Dina; Vazquez, Jose A. // Clinical Infectious Diseases;11/1/2002, Vol. 35 Issue 9, p1066 

    Twelve women with vaginal Candida krusei infection were evaluated. In vitro antifungal susceptibility testing and molecular typing were performed. Patients infected with C. krusei frequently had refractory vulvovaginal signs and symptoms that were otherwise indistinguishable from vaginitis due...

  • Vaginal thrush: treating and advising the patient. Holloway, Debra // British Journal of Nursing;12/6/2011, Vol. 20 Issue 22, p1410 

    No abstract available.

  • Antifungal susceptibility testing of vaginal candida isolates:the broth microdilution method. Mahmoudi Rad, M.; Zafarghandi, A. S.; Shivaei, M.; Mahmoudi Rad, N.; Abbasabadi, B.; Zabihi, M. Amel; Amiri, Z. // Tehran University Medical Journal;Feb2010, Vol. 67 Issue 11, p793 

    Background: Vulvovaginal candidiasis is a common mucosal infection among immunocompetent, healthy women, and is caused by opportunistic yeasts that belong to genus Candida. In this study, we isolated and identified the Candida species in the vagina of patients who admitted in Gynecology...

  • USE OF ANTIFUNGAL SAPONIN SC-2 OF SOLANUM CHRYSOTRICHUM FOR THE TREATMENT OF VULVOVAGINAL CANDIDIASIS: IN VITRO STUDIES AND CLINICAL EXPERIENCES. Herrera-Arellano, Armando; López-Villegas, Edgar O.; Rodríguez-Tovar, Aida V.; Zamilpa, Alejandro; Jiménez-Ferrer, Enrique; Tortoriello, Jaime; Martínez-Rivera, M. Angeles // African Journal of Traditional, Complementary & Alternative Medi;2013, Vol. 10 Issue 3, p410 

    Saponin SC-2 from Solanum chrysotrichum showed antifungal activity, demonstrated in vitro, which inhibited the growth of dermatophytes, and in vivo, to be effective in the treatment against tinea pedis and pityriasis capitis. Fungistatic and fungicidal activity of saponin SC-2 on Candida...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics